19,11 .beta.-bridged steroids, their manufacture and pharmaceutical preparations containing them

New 19,11.beta.-bridged steroids of the general formula I ##STR1## where R.sup.1 stands for a methyl or ethyl radical, PA0 R.sup.2 for a hydrogen or chlorine atom or a C.sub.1 -C.sub.4 -alkyl radical, PA0 B and G, which are the same or different, respectively for a hydrogen atom, a C.sub.1 -C.sub.4 -alkyl radical or, together, for a second bond between the carbon atoms 6 and 7, PA0 B and R.sup.2 together for a methylene or an ethylene group, PA0 Z for the radical of a pentagonal or hexagonal ring, which is possibly substituted and possibly unsaturated, PA0 V stands for a possibly substituted carbocyclic or heterocyclic aryl radical, PA0 the ring A for ##STR2## M and N together meaning a second bond or M a hydrogen atom and N a hydroxy group, PA0 X means an oxygen atom, two hydrogen atoms or a hydroxyimino grouping N.about.OH, PA0 R.sup.3 and D, which are the same or different, respectively a hydrogen atom, a nitrile radical or a C.sub.1 -C.sub.4 -alkyl radical or, together, a methylene or ethylene group, PA0 E a hydrogen atom or a C.sub.1 -C.sub.4 -alkyl radical, PA0 D and E together meaning a second bond between carbon atoms 1 and 2 or together a methylene group ##STR3## with R.sup.11 in the meaning of a hydrogen atom or a C.sub.1 -C.sub.8 -alkyl radical, are described as well as their pharmaceutically tolerated addition salts with acids. The new compounds possess valuable pharmacological properties.